TKPHF Projected Dividend Yield
Ord/Takeda Pharmaceutical Co Ltd ( OTCBB : TKPHF )Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. Co. has a geographically diversified global business and provides its prescription drugs in Japan and overseas. Co.'s principal pharmaceuticals are antidiabetic, antihypertensive medicine, drugs for multiple myeloma and mantle cell lymphoma, medicine for reflux esophagitis, and hyperuricemia treatment. Co. focuses its R&D activities on four core therapeutic areas of oncology, rare genetics and hemotology, neuroscience, gastroenterology, plasma-derived therapies and vaccines. 26 YEAR PERFORMANCE RESULTS |
TKPHF Dividend History Detail TKPHF Dividend News TKPHF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (JPY) |
2024 |
N/A |
N/A |
Mar 29, 2024 |
Jun 27, 2024 |
94.0000 |
2024 Total: |
94.0000 |
||||
2023 |
N/A |
N/A |
Sep 30, 2023 |
Dec 01, 2023 |
94.0000 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jun 29, 2023 |
90.0000 |
2023 Total: |
184.0000 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 01, 2022 |
90.0000 |
2022 |
N/A |
N/A |
Mar 31, 2022 |
Jun 30, 2022 |
90.0000 |
2022 Total: |
180.0000 |
||||
2021 |
N/A |
N/A |
Sep 30, 2021 |
Dec 01, 2021 |
90.0000 |
2021 |
N/A |
N/A |
Mar 31, 2021 |
Jun 30, 2021 |
90.0000 |
2021 Total: |
180.0000 |
||||
2020 |
N/A |
N/A |
Sep 30, 2020 |
Dec 01, 2020 |
90.0000 |
2020 |
N/A |
N/A |
Mar 31, 2020 |
Jun 25, 2020 |
90.0000 |
2020 Total: |
180.0000 |
||||
2019 |
N/A |
N/A |
Sep 30, 2019 |
Dec 02, 2019 |
90.0000 |
2019 |
N/A |
N/A |
Mar 31, 2019 |
Jun 28, 2019 |
90.0000 |
2019 Total: |
180.0000 |